Phase 2 Infections Clinical Trials
53 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 53 trials
Recruiting
Phase 2
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
LymphomaEpstein-Barr Virus InfectionsLymphoproliferative Disorder+1 more
National Cancer Institute (NCI)40 enrolled1 locationNCT03258567
Recruiting
Phase 2
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
Salmonella Infections
GlaxoSmithKline537 enrolled1 locationNCT07286370
Recruiting
Phase 1Phase 2
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Phase 1Phase 2
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
Urinary Tract Infections
GlaxoSmithKline448 enrolled8 locationsNCT06702449
Recruiting
Phase 2
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
Recurrent Respiratory Tract Infections
Min-Tze LIONG120 enrolled2 locationsNCT07297966
Recruiting
Phase 1Phase 2
CAR-T Cells for HIV Infection
HIV Infections
Steven Deeks18 enrolled2 locationsNCT04648046
Recruiting
Phase 2
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Respiratory Syncytial Virus Infections
Shionogi192 enrolled64 locationsNCT07214571
Recruiting
Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Locus Biosciences318 enrolled17 locationsNCT05488340
Recruiting
Phase 1Phase 2
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS52 enrolled1 locationNCT04759001
Recruiting
Phase 2
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Neurogenic BladderPost-operative Urinary Tract Infections
University of Alberta160 enrolled1 locationNCT04791579
Recruiting
Phase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
ViiV Healthcare150 enrolled62 locationsNCT07202546
Recruiting
Phase 2
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Respiratory Syncytial Virus Infections
GlaxoSmithKline184 enrolled37 locationsNCT07092865
Recruiting
Phase 2
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 2Phase 3
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Phase 2
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
InfectionsAcute Respiratory Distress Syndrome
BioAegis Therapeutics Inc.600 enrolled76 locationsNCT05947955
Recruiting
Phase 1Phase 2
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088
Recruiting
Phase 2
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Phase 1Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc.137 enrolled11 locationsNCT05655182
Recruiting
Phase 2Phase 3
Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old
Meningococcal Infections
EyeGene Inc.1,123 enrolled1 locationNCT07204457
Recruiting
Phase 2
Azithromycin for Meningococcal Carriage
Meningococcal Infections
Emory University1,120 enrolled1 locationNCT06618534